Comparison of Illumina and 454 Deep Sequencing in Participants Failing Raltegravir-Based Antiretroviral Therapy
暂无分享,去创建一个
Alyssa J. Porter | M. Zody | M. Lederman | B. Weiner | Winston A Hide | D. Kuritzkes | O. Hofmann | M. Henn | R. Leavitt | E. Acosta | B. Chapman | B. Taiwo | B. Berzins | Jonathan Z. Li | J. Eron | P. Charlebois | Reshmi Samuel | S. Vardhanabhuti | Lu Zheng | Cara C Wilson | B. Bastow | Peter S. Kim | Sarah W. Read | Jennifer Janik | D. Meres | L. Mong-Kryspin | K. Shaw | Louis G. Zimmerman | G. de la Rosa | A. Jennings | G. De La Rosa | Oliver M. Hofmann
[1] Eric Lonstein,et al. Prize-based contests can provide solutions to computational biology problems , 2013, Nature Biotechnology.
[2] J. Archer,et al. Use of Four Next-Generation Sequencing Platforms to Determine HIV-1 Coreceptor Tropism , 2012, PloS one.
[3] Niko Beerenwinkel,et al. Read length versus Depth of Coverage for Viral Quasispecies Reconstruction , 2012, PloS one.
[4] Michael C. Zody,et al. Highly Sensitive and Specific Detection of Rare Variants in Mixed Viral Populations from Massively Parallel Sequence Data , 2012, PLoS Comput. Biol..
[5] Huldrych F. Günthard,et al. Whole Genome Deep Sequencing of HIV-1 Reveals the Impact of Early Minor Variants Upon Immune Recognition During Acute Infection , 2012, PLoS pathogens.
[6] F. Ceccherini‐Silberstein,et al. Study of genotypic and phenotypic HIV-1 dynamics of integrase mutations during raltegravir treatment: a refined analysis by ultra-deep 454 pyrosequencing. , 2012, The Journal of infectious diseases.
[7] N. Kyrpides,et al. Direct Comparisons of Illumina vs. Roche 454 Sequencing Technologies on the Same Microbial Community DNA Sample , 2012, PloS one.
[8] David L. Robertson,et al. Analysis of high-depth sequence data for studying viral diversity: a comparison of next generation sequencing platforms using Segminator II , 2012, BMC Bioinformatics.
[9] Cassandra B. Jabara,et al. Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer ID , 2011, Proceedings of the National Academy of Sciences.
[10] D. Kuritzkes,et al. Efficacy of a nucleoside-sparing regimen of darunavir/ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262) , 2011, AIDS.
[11] Richard L. Hodinka,et al. Switching between raltegravir resistance pathways analyzed by deep sequencing , 2011, AIDS.
[12] M. Hughes,et al. Role of low-frequency HIV-1 variants in failure of nevirapine-containing antiviral therapy in women previously exposed to single-dose nevirapine , 2011, Proceedings of the National Academy of Sciences.
[13] Soo-Yon Rhee,et al. HIV-1 Integrase Inhibitor Resistance and Its Clinical Implications , 2011, The Journal of infectious diseases.
[14] K. Metzner,et al. Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis. , 2011, JAMA.
[15] Feng Gao,et al. Analysis of Low-Frequency Mutations Associated with Drug Resistance to Raltegravir before Antiretroviral Treatment , 2010, Antimicrobial Agents and Chemotherapy.
[16] R. Paredes,et al. Dynamic escape of pre-existing raltegravir-resistant HIV-1 from raltegravir selection pressure. , 2010, Antiviral research.
[17] M. DePristo,et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.
[18] F. Ceccherini‐Silberstein,et al. Secondary Integrase Resistance Mutations Found in HIV-1 Minority Quasispecies in Integrase Therapy-Naive Patients Have Little or No Effect on Susceptibility to Integrase Inhibitors , 2010, Antimicrobial Agents and Chemotherapy.
[19] C. Charpentier,et al. High frequency of integrase Q148R minority variants in HIV-infected patients naive of integrase inhibitors , 2010, AIDS.
[20] J. Eshleman,et al. Sensitivity of the ViroSeq HIV-1 genotyping system for detection of the K103N resistance mutation in HIV-1 subtypes A, C, and D. , 2006, The Journal of molecular diagnostics : JMD.
[21] B. Larder,et al. Quantitative detection of HIV-1 drug resistance mutations by automated DNA sequencing , 1993, Nature.